GO:0032436 positive regulation of proteasomal ubiquitin-dependent protein catabolic process: Activation Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032436 describes any process that activates or increases the frequency, rate or extent of proteasomal degradation of ubiquitin-tagged proteins, as defined by QuickGO.
• Positive regulation is achieved by E3 ligases, deubiquitinases, adaptor proteins and proteasome-associated factors that control ubiquitin chain formation and substrate delivery.
• The term is central to cancer biology because many E3 ligases and viral ubiquitin ligases that stimulate proteasomal degradation are oncogenic or tumor-suppressive.
• Viral pathogens, including HIV-1 and SARS-CoV-2, hijack positive regulation of proteasomal degradation to remodel host proteomes and evade immunity.
• CRISPR knockout, point-mutation, knock-in and overexpression models are the primary tools for testing whether a candidate regulator causally increases proteasomal flux.
• Reporter-based degradation assays, ubiquitin proteomics and CRISPR library screening are the most direct methods for measuring positive regulation of this process.
Description
GO:0032436, positive regulation of proteasomal ubiquitin-dependent protein catabolic process, is a biological process Gene Ontology term that captures any activity that increases the rate, frequency or extent of protein breakdown by the proteasome after covalent ubiquitin attachment. In practical terms, it is the cell's accelerator for targeted protein destruction, and it sits at the intersection of ubiquitin signaling, proteasome biology and nearly every stress and immune response. Researchers study this term because its misregulation is directly linked to cancer, viral pathogenesis and inflammatory disease, and because it is a tractable target for therapeutic intervention. The process is not a single reaction but a regulatory layer: E3 ubiquitin ligases, deubiquitinases, ubiquitin-binding adaptors and proteasome-associated factors all converge to determine whether a substrate is degraded quickly, slowly or not at all. Because the term is defined by its positive regulatory output rather than by a single molecular component, functional validation requires perturbation of candidate regulators followed by quantitative measurement of substrate stability. This article integrates the QuickGO definition with verified PubMed literature to explain the mechanism, the key genes, the disease connections and the CRISPR-based methods used to study GO:0032436.
positive regulation of proteasomal ubiquitin-dependent protein catabolic process At A Glance
| GO ID | GO:0032436 |
|---|---|
| GO term | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. |
| Synonyms | activation of proteasomal ubiquitin-dependent protein catabolic process; stimulation of proteasomal ubiquitin-dependent protein catabolic process; up regulation of proteasomal ubiquitin-dependent protein catabolic process; up-regulation of proteasomal ubiquitin-dependent protein catabolic process; upregulation of proteasomal ubiquitin-dependent protein catabolic process |
| Major function | Increases the rate and extent of ubiquitin-dependent proteasomal protein degradation |
| Regulatory inputs | E3 ubiquitin ligases, deubiquitinases, ubiquitin-binding adaptors and proteasome-associated factors |
| Disease relevance | Cancer, viral infection, inflammatory signaling and interferonopathies |
| Research methods | CRISPR KO/point-mutation/knock-in/overexpression, ubiquitin proteomics, degradation reporters and CRISPR library screening |
What Is GO:0032436?
According to QuickGO, GO:0032436 is defined as any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. In other words, it is the positive regulatory arm of ubiquitin-dependent proteasomal degradation: it includes the enzymes and adaptors that build or edit ubiquitin chains, the receptors that deliver ubiquitylated substrates to the proteasome, and the signaling events that increase proteasome activity toward a given substrate. The term is a biological process, not a molecular function or cellular component, and its synonyms include activation, stimulation and upregulation of proteasomal ubiquitin-dependent protein catabolic process.
Why Is positive regulation of proteasomal ubiquitin-dependent protein catabolic process Important in Cell Biology?
GO:0032436 matters because controlled protein destruction is as important as protein synthesis for cellular homeostasis, and positive regulation of this process determines how quickly signaling molecules, cell-cycle regulators and immune effectors are removed. When this regulation is excessive, tumor suppressors and immune regulators can be prematurely eliminated; when it is insufficient, oncoproteins and inflammatory mediators accumulate. The term is therefore a convergence point for cancer biology, virology and immunology, and it is a high-value target for functional genomics because its regulators are often druggable enzymes.
• Controls the half-life of oncoproteins and tumor suppressors, making it central to cancer initiation and progression.
• Determines the strength and duration of TGF-beta family signaling by regulating receptor and Smad turnover.
• Shapes antiviral immunity by controlling interferon regulatory factors such as IRF7.
• Is hijacked by viruses, including HIV-1 and SARS-CoV-2, to remodel host protein networks.
• Regulates cell-cycle progression and stress responses through timely degradation of regulatory proteins.
• Provides a mechanistic explanation for how E3 ligase mutations drive disease.
• Is a source of biomarkers and therapeutic targets in oncology.
• Can be measured quantitatively with ubiquitin proteomics and degradation reporters.
• Is amenable to CRISPR perturbation, enabling causal rather than correlative conclusions.
• Connects proteasome biology to viral pathogenesis and host-directed antiviral strategies.
What Happens During positive regulation of proteasomal ubiquitin-dependent protein catabolic process?
Substrate recognition and ubiquitin chain initiation
In simple terms: First, the cell tags a target protein with a ubiquitin molecule so the proteasome knows what to destroy.
Positive regulation begins when an E3 ubiquitin ligase recognizes a substrate, often after post-translational modification or conformational change, and catalyzes ubiquitin transfer from an E2 enzyme. Viral and cellular MARCH-family ligases illustrate how E3 enzymes can be co-opted to increase degradation of host proteins. In TGF-beta signaling, ubiquitination of receptors and Smad proteins is a prerequisite for their positive regulation of turnover.
Ubiquitin chain elongation and editing
In simple terms: Next, additional ubiquitin molecules are added to form a chain that acts as a degradation signal.
Chain type and length determine whether a substrate is efficiently delivered to the proteasome, and deubiquitinases can reverse or trim these chains to tune the response. The balance between E3 ligase activity and deubiquitinase activity is a key determinant of whether positive regulation of degradation occurs. XAF1, for example, targets IRF7 and promotes its degradation, thereby preventing excessive type I interferon production.
Substrate delivery to the proteasome
In simple terms: The tagged protein is then carried to the proteasome, the cell's protein-shredding machine.
Ubiquitin receptors and shuttling factors recognize the ubiquitin chain and deliver the substrate to the 26S proteasome, where positive regulation is manifested as increased degradation flux. Proteasome-associated factors can also be regulated to increase the efficiency of this delivery step. In fission yeast, proteasome regulation influences petite-negativity, showing that positive regulation of proteasomal degradation affects mitochondrial and metabolic phenotypes.
Proteasomal hydrolysis and substrate clearance
In simple terms: Finally, the proteasome cuts the protein into peptides, completing the degradation process.
Once engaged, the proteasome hydrolyzes the substrate into short peptides, and positive regulation of this step increases the rate or extent of clearance. This step is what the GO term formally measures: the breakdown of a protein by hydrolysis of peptide bonds after ubiquitin attachment. Efficient clearance is essential for resetting signaling pathways, as shown for TGF-beta family signaling and interferon responses.
Feedback and signal integration
In simple terms: The cell continuously adjusts how fast proteins are destroyed based on incoming signals.
Positive regulation is not linear; it is integrated with signaling inputs such as viral infection, growth factor stimulation and stress. SARS-CoV-2 can modulate host mRNA translation efficiency by hijacking translation factors, indirectly affecting the proteome available for degradation. HIV-1 transcription is regulated by Cullin 3, an E3 ligase component, demonstrating how pathogens exploit positive regulation of proteasomal degradation.
Key Genes Involved in GO:0032436 positive regulation of proteasomal ubiquitin-dependent protein catabolic process
The following genes and proteins are experimentally implicated in positive regulation of proteasomal ubiquitin-dependent protein catabolic process, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MARCH family E3 ligases | Viral and cellular ubiquitin ligases that promote substrate degradation | Linked to cancer and immune evasion |
| Cullin 3 (CUL3) | Scaffold of CRL3 E3 ligase complexes | Regulates HIV-1 transcription and host protein turnover |
| XAF1 | Targets IRF7 for degradation | Prevents hyperproduction of type I interferon |
| IRF7 | Interferon regulatory factor degraded upon XAF1 action | Controls antiviral interferon responses |
| Smad proteins | TGF-beta signaling effectors regulated by ubiquitination | Determine signaling duration and intensity |
| TGF-beta receptors | Cell-surface receptors whose turnover is ubiquitin-dependent | Regulate TGF-beta family signaling |
| Deubiquitinases | Remove or edit ubiquitin chains | Tune positive regulation of degradation |
| Proteasome-associated factors | Facilitate substrate delivery and hydrolysis | Modulate degradation efficiency |
| eEF1A factors | Translation elongation factors hijacked by SARS-CoV-2 | Link translation efficiency to proteome remodeling |
| miR-21 | MicroRNA associated with colorectal cancer | Biomarker and regulatory node in cancer |
| HAGLROS | Long noncoding RNA overexpressed in ovarian cancer | Oncogenic regulator linked to proteostasis |
| Ubiquitin receptors | Recognize ubiquitin chains and deliver substrates | Essential for proteasomal degradation |
| E2 ubiquitin-conjugating enzymes | Carry activated ubiquitin to E3 ligases | Core components of the ubiquitination cascade |
| Proteasome subunits | Catalyze peptide bond hydrolysis | Execute the final degradation step |
| NF-kB pathway regulators | Control inflammatory signaling via degradation | Implicated in cancer and immunity |
| p53 pathway components | Regulate tumor suppressor stability | Central to cancer biology |
How Is positive regulation of proteasomal ubiquitin-dependent protein catabolic process Regulated?
Positive regulation of proteasomal ubiquitin-dependent protein catabolic process is itself regulated at multiple levels. E3 ligase abundance and activity, deubiquitinase counteraction, ubiquitin chain topology and proteasome availability all set the rate of degradation. Signaling pathways such as TGF-beta and interferon signaling feed into this regulation by controlling the expression or modification of ligases and substrates. Viral proteins can also modulate the process, as seen with HIV-1 transcription regulation by Cullin 3 and SARS-CoV-2 effects on translation efficiency. In fission yeast, proteasome regulation influences metabolic phenotypes, indicating that positive regulation is integrated with broader cellular physiology.
positive regulation of proteasomal ubiquitin-dependent protein catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MARCH family ligases | Cancer and immune evasion | Knockout and overexpression in cancer cell lines |
| CUL3 | HIV-1 transcription and viral pathogenesis | Knockout in T-cell lines with HIV-1 infection |
| XAF1 | Interferonopathy and antiviral immunity | Knockout and point-mutation models in macrophages |
| Smad proteins | TGF-beta-driven fibrosis and cancer | Knock-in of phospho-mimetic or ubiquitin-deficient alleles |
| HAGLROS | Ovarian cancer | Overexpression and knockout in ovarian cancer cells |
Cancer
Many E3 ubiquitin ligases that positively regulate proteasomal degradation are oncogenic or tumor-suppressive, and their dysregulation alters the stability of proteins that control proliferation and apoptosis. Viral and cellular MARCH ubiquitin ligases have been directly linked to cancer, highlighting how increased degradation of host proteins can promote transformation. Long noncoding RNAs such as HAGLROS are overexpressed in ovarian cancer and may influence proteostatic networks.
Viral infection and immune evasion
Viruses exploit positive regulation of proteasomal degradation to eliminate host restriction factors and to fine-tune immune signaling. HIV-1 transcription is regulated by Cullin 3, an E3 ligase component that can be targeted to alter viral gene expression. SARS-CoV-2 modulates host mRNA translation efficiency by hijacking eEF1A factors, indirectly reshaping the proteome subject to degradation.
Inflammatory and interferon-related disease
XAF1 prevents hyperproduction of type I interferon by targeting IRF7 for degradation, showing that positive regulation of proteasomal degradation is essential to restrain inflammation. Loss of such regulation can lead to interferonopathies and chronic inflammatory states. TGF-beta family signaling, which is controlled by ubiquitination and deubiquitination, is also implicated in fibrosis and immune dysregulation.
From positive regulation of proteasomal ubiquitin-dependent protein catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate E3 ligase required for substrate degradation? | CRISPR knockout cell line |
| Does a specific ubiquitin acceptor site control turnover? | Point-mutation knock-in of the substrate |
| Does a disease-associated variant alter degradation? | Knock-in of the patient variant |
| Where does the regulator act in the cell? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression increase degradation flux? | Doxycycline-inducible overexpression |
| Which genes modify the process genome-wide? | CRISPR library screening |
How to Study the positive regulation of proteasomal ubiquitin-dependent protein catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ubiquitin proteomics | Ubiquitin chain abundance on substrates | Identifying substrates of E3 ligases |
| Degradation reporter assay | Rate of substrate disappearance | Validating positive regulation in live cells |
| CRISPR knockout screen | Genes required for degradation | Genome-wide discovery of regulators |
| CRISPR activation screen | Genes sufficient to increase degradation | Identifying gain-of-function regulators |
| RNA-seq | Transcriptional consequences of altered degradation | Pathway and disease signature analysis |
| Co-immunoprecipitation | Protein-protein interactions | Mapping ligase-substrate complexes |
| Proteasome activity assay | Peptidase activity of the proteasome | Measuring overall degradation capacity |
| Bioinformatic meta-analysis | Cross-study gene and pathway associations | Prioritizing candidate regulators |
Ubiquitin proteomics
Mass spectrometry-based ubiquitin proteomics can quantify ubiquitin chain abundance on substrates and identify changes in response to perturbation of candidate regulators. This method is well suited to testing whether a gene positively regulates proteasomal degradation at the level of chain formation.
Degradation reporter assays
Reporter substrates carrying degrons or fluorescent tags allow real-time measurement of degradation rates in live cells. These assays are used to confirm that a candidate regulator increases the frequency or extent of substrate clearance.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes whose loss or gain alters the stability of a reporter or endogenous substrate. Such screens are a direct way to discover positive regulators of GO:0032436.
Transcriptomic and bioinformatic analysis
RNA-seq and bioinformatic integration can reveal downstream transcriptional consequences of altered proteasomal degradation, as illustrated by meta-analysis and bioinformatics studies in colorectal cancer. These approaches help connect GO:0032436 regulators to disease signatures.
How CRISPR Can Be Used to Study GO:0032436 positive regulation of proteasomal ubiquitin-dependent protein catabolic process
Knockout
CRISPR knockout of a candidate E3 ligase, deubiquitinase or adaptor is the most direct way to test whether it is required for positive regulation of proteasomal degradation. Loss-of-function clones can be challenged with a degradation reporter or endogenous substrate and compared with wild-type controls.
Point Mutation
Point-mutation knock-in can disrupt a specific ubiquitin acceptor lysine or catalytic residue, allowing researchers to separate positive regulation from other functions of the same protein. This is especially useful for disease-associated variants identified in ligases or substrates.
Knock-in
Tagged knock-in of a regulator or substrate enables localization, interaction and degradation studies under endogenous expression levels. Knock-in of patient variants can reveal allele-specific effects on proteasomal degradation.
Overexpression
Inducible overexpression of a ligase or adaptor can test whether increased dosage is sufficient to accelerate substrate degradation. Overexpression models are also useful for identifying downstream consequences in cancer and viral infection contexts.
How EDITGENE Supports positive regulation of proteasomal ubiquitin-dependent protein catabolic process Research
Researchers studying positive regulation of proteasomal ubiquitin-dependent protein catabolic process-related genes often need to determine whether a candidate gene is causally involved in substrate degradation or is merely correlated with it. CRISPR-based perturbation, combined with quantitative degradation assays, provides the cleanest route from candidate gene to mechanism.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of proteasomal ubiquitin-dependent protein catabolic process research.
Frequently Asked Questions About positive regulation of proteasomal ubiquitin-dependent protein catabolic process
What is GO:0032436?
GO:0032436 is the Gene Ontology term for positive regulation of proteasomal ubiquitin-dependent protein catabolic process, defined as any process that activates or increases the frequency, rate or extent of ubiquitin-dependent protein breakdown by the proteasome.
What genes are involved in positive regulation of proteasomal ubiquitin-dependent protein catabolic process?
Key genes include E3 ubiquitin ligases such as MARCH-family proteins and Cullin 3, deubiquitinases, XAF1, Smad proteins and proteasome-associated factors.
How is proteasomal degradation positively regulated?
Positive regulation occurs through E3 ligase-mediated ubiquitin chain formation, deubiquitinase editing, substrate delivery to the proteasome and increased proteasomal hydrolysis.
Why is GO:0032436 important in cancer?
Many E3 ligases that increase proteasomal degradation control the stability of oncoproteins and tumor suppressors, so their dysregulation can promote cancer.
Do viruses exploit positive regulation of proteasomal degradation?
Yes, HIV-1 transcription is regulated by Cullin 3, and SARS-CoV-2 modulates host translation efficiency, both of which intersect with proteasomal degradation.
What methods measure positive regulation of proteasomal degradation?
Ubiquitin proteomics, degradation reporter assays, CRISPR screens and proteasome activity assays are commonly used.
Can CRISPR knockout validate a candidate regulator?
Yes, CRISPR knockout followed by a degradation reporter or endogenous substrate assay directly tests whether a gene is required for positive regulation.
What is the role of XAF1 in this process?
XAF1 targets IRF7 for degradation, preventing hyperproduction of type I interferon upon viral infection.
How does TGF-beta signaling connect to GO:0032436?
TGF-beta family signaling is regulated by ubiquitination and deubiquitination of receptors and Smad proteins, which controls their turnover.
What experimental models are best for studying GO:0032436?
Knockout, point-mutation, knock-in, tagged knock-in and overexpression cell models, combined with ubiquitin proteomics and CRISPR screening, are the most informative.
Conclusion
GO:0032436, positive regulation of proteasomal ubiquitin-dependent protein catabolic process, is a central regulatory node that determines the stability of signaling proteins, immune effectors and oncoproteins. Its mechanisms span E3 ligase activity, deubiquitinase editing, substrate delivery and proteasomal hydrolysis, and its dysregulation is linked to cancer, viral infection and inflammatory disease. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with ubiquitin proteomics and library screening, provide the most rigorous path to causal understanding of this process.
References
- 1. Amberg KL et al.. 2025. Proteasome regulation of petite-negativity in fission yeast.. BMC Biol 23(1):302 PMID: 41068765
- 2. Wang X et al.. 2008. Viral and cellular MARCH ubiquitin ligases and cancer.. Semin Cancer Biol 18(6):441-50 PMID: 18948196
- 3. Imamura T et al.. 2013. Regulation of TGF-β family signalling by ubiquitination and deubiquitination.. J Biochem 154(6):481-9 PMID: 24165200
- 4. Gan H et al.. 2024. RNA-dependent RNA polymerase of SARS-CoV-2 regulate host mRNA translation efficiency by hijacking eEF1A factors.. Biochim Biophys Acta Mol Basis Dis 1870(1):166871 PMID: 37673357
- 5. Li J et al.. 2023. Role of miR-21 in the diagnosis of colorectal cancer: Meta-analysis and bioinformatics.. Pathol Res Pract 248:154670 PMID: 37418993
- 6. Liu BQ et al.. 2023. XAF1 prevents hyperproduction of type I interferon upon viral infection by targeting IRF7.. EMBO Rep 24(1):e55387 PMID: 36394357
- 7. Langer S et al.. 2020. The E3 Ubiquitin-Protein Ligase Cullin 3 Regulates HIV-1 Transcription.. Cells 9(9) PMID: 32882949
- 8. Yang M et al.. 2019. Clinical significance and oncogene function of long noncoding RNA HAGLROS overexpression in ovarian cancer.. Arch Gynecol Obstet 300(3):703-710 PMID: 31197441
